Dr. Perry Maxwell Dansky, MD

Dr. Dansky practices at Saint Francis Hospital in Hartford, Connecticut, part of Trinity Health.

Dr. Dansky's NPI, 1013019769, was assigned on September 2, 2006. Dr. Dansky holds Connecticut license 031474.

Dr. Dansky's primary practice is Saint Francis Hospital, at 114 Woodland Street & 500 Blue Hills Avenue, Hartford, CT 06105 in Hartford County. The practice phone is (860) 714-5541.

Dr. Dansky's primary practice is Saint Francis Hospital in Hartford, Connecticut, part of Trinity Health. The medical group on file is Vituity. Dmand AI also links Dr. Dansky to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dansky practices. Vendor and product names are available with a free account.

Emergency medicine is Dr. Dansky's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Dansky is licensed in Connecticut.

CMS data shows 639 Medicare services from Dr. Dansky across 5 procedure codes in 2024, for 554 Medicare patients. Medicare paid $66,848 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 554 Medicare patients who saw Dr. Dansky in 2024. The largest group is 75 to 84, with 180 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dansky's median patient age at 72, with 58% women.

In 2024, Dr. Dansky wrote 508 Medicare Part D claims for 371 patients. 93% of them were for generic drugs. CMS names the drug for 370 of them, across 12 drugs with 11 or more claims each, at $3,202 in total drug cost. In 2023, CMS named 467 claims across 15 drugs.

Dr. Dansky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Dr. Dansky from 4 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Bristol-Myers Squibb Company paid the most, $59.